| (S)-colchicine | decreases expression | EXP | | 6480464 | Colchicine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| 1,4-benzoquinone | multiple interactions | EXP | | 6480464 | benzoquinone promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:16180106 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:736497 | 6480464 | Ethinyl Estradiol affects the expression of MAPT mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736497 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPT mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736497 | 6480464 | Ethinyl Estradiol results in increased expression of MAPT mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased expression of MAPT protein] | CTD | PMID:20579400 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of MAPT protein | CTD | PMID:20579400 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAPT mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736497 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAPT mRNA | CTD | PMID:17942748 PMID:16922920 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases phosphorylation | ISO | RGD:736497 | 6480464 | Tetrachlorodibenzodioxin results in increased phosphorylation of MAPT protein | CTD | PMID:18996433 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736497 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAPT mRNA | CTD | PMID:16922920 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736497 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAPT mRNA | CTD | PMID:17942748 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of MAPT mRNA | CTD | PMID:21179406 |
| 3alpha-hydroxy-5beta-pregnan-20-one | increases phosphorylation | ISO | RGD:69329 | 6480464 | Pregnanolone results in increased phosphorylation of MAPT protein | CTD | PMID:17443805 |
| 3alpha-hydroxy-5beta-pregnan-20-one | decreases expression | ISO | RGD:69329 | 6480464 | Pregnanolone results in decreased expression of MAPT protein | CTD | PMID:17443805 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of MAPT mRNA | CTD | PMID:16570282 |
| 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| 5alpha-pregnane-3,20-dione | decreases expression | ISO | RGD:69329 | 6480464 | 5-alpha-Dihydroprogesterone results in decreased expression of MAPT protein | CTD | PMID:17443805 |
| 5alpha-pregnane-3,20-dione | increases phosphorylation | ISO | RGD:69329 | 6480464 | 5-alpha-Dihydroprogesterone results in increased phosphorylation of MAPT protein | CTD | PMID:17443805 |
| 8-azaguanine | decreases expression | EXP | | 6480464 | Azaguanine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPT mRNA | CTD | PMID:22079614 |
| acrolein | increases phosphorylation | EXP | | 6480464 | Acrolein results in increased phosphorylation of MAPT protein | CTD | PMID:12605413 |
| acrolein | increases phosphorylation | ISO | RGD:736497 | 6480464 | Acrolein results in increased phosphorylation of MAPT protein | CTD | PMID:12605413 |
| acrolein | multiple interactions | ISO | RGD:736497 | 6480464 | Acrolein promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17082178 |
| acrolein | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein]; more ... | CTD | PMID:12605413 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of MAPT protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MAPT mRNA | CTD | PMID:21641981 PMID:22100608 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of MAPT mRNA | CTD | PMID:21641981 |
| albendazole | decreases expression | EXP | | 6480464 | Albendazole results in decreased expression of MAPT mRNA; more ... | CTD | PMID:16930453 |
| alexidine | decreases expression | EXP | | 6480464 | alexidine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| all-trans-retinoic acid | affects response to substance | EXP | | 6480464 | MAPT protein affects the susceptibility to Tretinoin | CTD | PMID:16417947 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69329 | 6480464 | Tretinoin results in increased expression of MAPT protein | CTD | PMID:17130476 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | MAPT protein promotes the reaction [Tretinoin affects the localization of MAPT protein]; more ... | CTD | PMID:16417947 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:736497 | 6480464 | MAPT protein promotes the reaction [Tretinoin results in increased activity of CASP3 protein] | CTD | PMID:16417947 |
| aluminium atom | increases phosphorylation | ISO | RGD:69329 | 6480464 | Aluminum results in increased phosphorylation of MAPT protein | CTD | PMID:17662457 |
| aluminium(0) | increases phosphorylation | ISO | RGD:69329 | 6480464 | Aluminum results in increased phosphorylation of MAPT protein | CTD | PMID:17662457 |
| ammonium chloride | affects expression | ISO | RGD:69329 | 6480464 | Ammonium Chloride affects the expression of MAPT mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases expression | ISO | RGD:69329 | 6480464 | Ammonium Chloride results in decreased expression of MAPT protein modified form | CTD | PMID:16483693 |
| arachidonic acid | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Arachidonic Acid results in increased phosphorylation of MAPT protein] | CTD | PMID:12605413 |
| arachidonic acid | increases phosphorylation | EXP | | 6480464 | Arachidonic Acid results in increased phosphorylation of MAPT protein | CTD | PMID:12605413 |
| arsenic atom | affects expression | EXP | | 6480464 | Arsenic metabolite affects the expression of MAPT mRNA | CTD | PMID:17553662 |
| astemizole | affects binding | EXP | | 6480464 | Astemizole binds to MAPT protein alternative form | CTD | PMID:20110603 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MAPT mRNA | CTD | PMID:21871943 |
| benzo[a]pyrene | increases expression | ISO | RGD:736497 | 6480464 | Benzo(a)pyrene results in increased expression of MAPT mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736497 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MAPT mRNA] | CTD | PMID:22228805 |
| bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MAPT gene | CTD | PMID:22576693 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAPT mRNA | CTD | PMID:22576693 |
| camptothecin | decreases expression | EXP | | 6480464 | Camptothecin results in decreased expression of MAPT mRNA; more ... | CTD | PMID:16930453 |
| chelidonine | decreases expression | EXP | | 6480464 | chelidonine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| chloroquine | affects expression | ISO | RGD:69329 | 6480464 | Chloroquine affects the expression of MAPT mRNA; more ... | CTD | PMID:9690670 |
| chloroquine | multiple interactions | ISO | RGD:69329 | 6480464 | Chloroquine affects the localization of and affects the degradation of MAPT protein | CTD | PMID:9690670 |
| ciclopirox | decreases expression | EXP | | 6480464 | ciclopirox results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:736497 | 6480464 | Ciguatoxins affects the expression of MAPT mRNA | CTD | PMID:18353800 |
| copper atom | decreases expression | ISO | RGD:69329 | 6480464 | Copper results in decreased expression of MAPT mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper binds to Thiosemicarbazones analog] which results in decreased phosphorylation of MAPT protein | CTD | PMID:19122148 |
| copper(0) | decreases expression | ISO | RGD:69329 | 6480464 | Copper results in decreased expression of MAPT mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper binds to Thiosemicarbazones analog] which results in decreased phosphorylation of MAPT protein | CTD | PMID:19122148 |
| cyclophosphamide | multiple interactions | EXP | | 6480464 | MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of MAPT mRNA | CTD | PMID:20106945 |
| daunorubicin | decreases expression | EXP | | 6480464 | Daunorubicin results in decreased expression of MAPT mRNA; more ... | CTD | PMID:16930453 |
| dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1,2,5,6-dibenzanthracene results in increased expression of MAPT mRNA | CTD | PMID:16269432 |
| diethylstilbestrol | decreases expression | ISO | RGD:69329 | 6480464 | Diethylstilbestrol results in decreased expression of MAPT mRNA | CTD | PMID:17005392 |
| dopamine | multiple interactions | EXP | | 6480464 | Dopamine metabolite promotes the reaction [MAPT protein binds to MAPT protein]; more ... | CTD | PMID:16180106 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| doxorubicin | multiple interactions | EXP | | 6480464 | MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| emetine | decreases expression | EXP | | 6480464 | Emetine results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| emodin | decreases expression | EXP | | 6480464 | Emodin results in decreased expression of MAPT mRNA | CTD | PMID:16045814 |
| formaldehyde | multiple interactions | EXP | | 6480464 | Formaldehyde affects the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17637844 |
| formaldehyde | multiple interactions | EXP | | 6480464 | Formaldehyde promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17241479 |
| fulvestrant | decreases expression | EXP | | 6480464 | fulvestrant results in decreased expression of MAPT protein | CTD | PMID:20579400 |
| glyoxal | multiple interactions | ISO | RGD:736497 | 6480464 | Glyoxal promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17082178 |
| harmine | multiple interactions | EXP | | 6480464 | Harmine inhibits the reaction [DYRK1A protein results in increased phosphorylation of MAPT protein] | CTD | PMID:21573099 |
| heparin | multiple interactions | EXP | | 6480464 | Heparin promotes the reaction [MAPT protein binds to MAPT protein]; more ... | CTD | PMID:20665688 |
| indole-3-methanol | affects expression | ISO | RGD:69329 | 6480464 | indole-3-carbinol affects the expression of MAPT mRNA | CTD | PMID:21396975 |
| ionomycin | decreases phosphorylation | ISO | RGD:736497 | 6480464 | Ionomycin results in decreased phosphorylation of MAPT protein | CTD | PMID:9200503 |
| ionomycin | decreases phosphorylation | ISO | RGD:69329 | 6480464 | Ionomycin results in decreased phosphorylation of MAPT protein | CTD | PMID:9200503 |
| ionomycin | multiple interactions | ISO | RGD:69329 | 6480464 | Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | CTD | PMID:9200503 |
| ionomycin | multiple interactions | ISO | RGD:736497 | 6480464 | Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | CTD | PMID:9200503 |
| ketamine | increases phosphorylation | ISO | RGD:736497 | 6480464 | Ketamine results in increased phosphorylation of MAPT protein | CTD | PMID:20093173 |
| lansoprazole | affects binding | EXP | | 6480464 | lansoprazole binds to MAPT protein alternative form | CTD | PMID:20110603 |
| lead(0) | affects phosphorylation | ISO | RGD:69329 | 6480464 | Lead affects the phosphorylation of MAPT protein | CTD | PMID:22342405 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [Acrolein results in increased phosphorylation of MAPT protein] | CTD | PMID:12605413 |
| lithium chloride | multiple interactions | ISO | RGD:69329 | 6480464 | [Lithium Chloride results in decreased activity of GSK3B protein] inhibits the reaction [manganese chloride results in increased phosphorylation of MAPT protein] | CTD | PMID:20937724 |
| malonaldehyde | multiple interactions | ISO | RGD:736497 | 6480464 | Malondialdehyde promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17082178 |
| manganese(II) chloride | multiple interactions | ISO | RGD:69329 | 6480464 | GSK3B protein affects the reaction [manganese chloride results in increased phosphorylation of MAPT protein]; more ... | CTD | PMID:20937724 |
| manganese(II) chloride | increases phosphorylation | ISO | RGD:69329 | 6480464 | manganese chloride results in increased phosphorylation of MAPT protein | CTD | PMID:20937724 |
| mebendazole | decreases expression | EXP | | 6480464 | Mebendazole results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| melatonin | multiple interactions | ISO | RGD:736497 | 6480464 | Melatonin inhibits the reaction [wortmannin results in increased phosphorylation of MAPT protein] | CTD | PMID:15842767 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPT protein] | CTD | PMID:10617124 |
| mercury dichloride | multiple interactions | EXP | | 6480464 | Mercuric Chloride promotes the reaction [Heparin promotes the reaction [MAPT protein binds to MAPT protein]]; more ... | CTD | PMID:20665688 |
| mercury dichloride | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Mercuric Chloride results in increased phosphorylation of MAPT protein] | CTD | PMID:10617124 |
| mercury dichloride | increases phosphorylation | EXP | | 6480464 | Mercuric Chloride results in increased phosphorylation of MAPT protein | CTD | PMID:10617124 |
| methamphetamine | multiple interactions | ISO | RGD:736497 | 6480464 | (1R-(exo,exo))-3-(4-fluorophenyl)-8-methyl-8- azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester inhibits the reaction [Methamphetamine results in decreased expression of MAPT mRNA] | CTD | PMID:11756511 |
| methamphetamine | decreases expression | ISO | RGD:736497 | 6480464 | Methamphetamine results in decreased expression of MAPT mRNA | CTD | PMID:11756511 |
| methylene blue | decreases expression | EXP | | 6480464 | Methylene Blue results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| methylene blue | increases expression | EXP | | 6480464 | Methylene Blue results in increased expression of MAPT mRNA | CTD | PMID:16930453 |
| methylglyoxal | multiple interactions | ISO | RGD:736497 | 6480464 | Pyruvaldehyde promotes the reaction [MAPT protein binds to MAPT protein] | CTD | PMID:17082178 |
| methylmercury chloride | increases expression | ISO | RGD:736497 | 6480464 | methylmercuric chloride results in increased expression of MAPT mRNA | CTD | PMID:20061341 |
| methylmercury chloride | decreases expression | ISO | RGD:69329 | 6480464 | methylmercuric chloride results in decreased expression of MAPT protein | CTD | PMID:20869980 |
| methylmercury chloride | multiple interactions | ISO | RGD:69329 | 6480464 | exoenzyme C3, Clostridium botulinum inhibits the reaction [methylmercuric chloride results in decreased expression of MAPT protein]; more ... | CTD | PMID:20869980 |
| microcystin-LR | affects phosphorylation | ISO | RGD:736497 | 6480464 | cyanoginosin LR affects the phosphorylation of MAPT protein | CTD | PMID:21934130 |
| microcystin-LR | multiple interactions | ISO | RGD:69329 | 6480464 | SB 203580 inhibits the reaction [cyanoginosin LR results in increased localization of MAPT protein]; more ... | CTD | PMID:22000993 |
| microcystin-LR | increases localization | ISO | RGD:69329 | 6480464 | cyanoginosin LR results in increased localization of MAPT protein | CTD | PMID:22000993 |
| microcystin-LR | increases phosphorylation | ISO | RGD:69329 | 6480464 | cyanoginosin LR results in increased phosphorylation of MAPT protein | CTD | PMID:22000993 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:736497 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of MAPT mRNA | CTD | PMID:22401849 |
| morphine | increases expression | ISO | RGD:69329 | 6480464 | Morphine results in increased expression of MAPT mRNA | CTD | PMID:15183518 |
| mycophenolic acid | decreases expression | EXP | | 6480464 | Mycophenolic Acid results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69329 | 6480464 | Diethylnitrosamine results in increased expression of and results in increased phosphorylation of MAPT protein | CTD | PMID:19542621 PMID:20387270 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69329 | 6480464 | Diethylnitrosamine results in increased expression of and results in increased phosphorylation of MAPT protein | CTD | PMID:20387270 PMID:19542621 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:69329 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MAPT mRNA | CTD | PMID:18164116 |
| nickel atom | decreases expression | ISO | RGD:736497 | 6480464 | Nickel results in decreased expression of MAPT mRNA | CTD | PMID:12540486 |
| nickel sulfate | decreases expression | ISO | RGD:736497 | 6480464 | nickel sulfate results in decreased expression of MAPT mRNA | CTD | PMID:16100012 |
| nocodazole | decreases expression | EXP | | 6480464 | Nocodazole results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| norethisterone | decreases expression | EXP | | 6480464 | Norethindrone results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| okadaic acid | multiple interactions | EXP | | 6480464 | [5-iodo-3-(2-azetidinylmethoxy)pyridine binds to and results in increased activity of CHRNB2 protein] inhibits the reaction [Okadaic Acid results in increased phosphorylation of MAPT protein]; more ... | CTD | PMID:21715663 |
| okadaic acid | affects phosphorylation | ISO | RGD:736497 | 6480464 | Okadaic Acid affects the phosphorylation of MAPT protein | CTD | PMID:21934130 |
| okadaic acid | increases phosphorylation | EXP | | 6480464 | Okadaic Acid results in increased phosphorylation of MAPT protein | CTD | PMID:7723735 PMID:21715663 |
| okadaic acid | increases phosphorylation | ISO | RGD:69329 | 6480464 | Okadaic Acid results in increased phosphorylation of MAPT protein | CTD | PMID:7723735 |
| okadaic acid | multiple interactions | ISO | RGD:69329 | 6480464 | Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein]; more ... | CTD | PMID:9200503 |
| okadaic acid | multiple interactions | ISO | RGD:69329 | 6480464 | [Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | CTD | PMID:7723735 |
| okadaic acid | multiple interactions | ISO | RGD:736497 | 6480464 | Okadaic Acid inhibits the reaction [Ionomycin results in decreased phosphorylation of MAPT protein] | CTD | PMID:9200503 |
| okadaic acid | increases phosphorylation | EXP | | 6480464 | Okadaic Acid results in increased phosphorylation of MAPT protein | CTD | PMID:21715663 PMID:7723735 |
| okadaic acid | multiple interactions | EXP | | 6480464 | [Okadaic Acid co-treated with immunomycin] results in increased phosphorylation of MAPT protein | CTD | PMID:7723735 |
| ozone | decreases expression | ISO | RGD:736497 | 6480464 | Ozone results in decreased expression of MAPT mRNA | CTD | PMID:12763052 |
| paclitaxel | multiple interactions | EXP | | 6480464 | MAPT mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | CTD | PMID:16896004 |
| paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of MAPT mRNA; more ... | CTD | PMID:16930453 |
| paracetamol | affects expression | ISO | RGD:736497 | 6480464 | Acetaminophen affects the expression of MAPT mRNA | CTD | PMID:17562736 |
| paraquat | multiple interactions | ISO | RGD:736497 | 6480464 | Paraquat results in increased phosphorylation of and results in increased expression of MAPT protein | CTD | PMID:22292029 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:736497 | 6480464 | perfluorooctane sulfonic acid results in increased expression of MAPT protein | CTD | PMID:19211617 |
| perfluorooctanoic acid | increases expression | ISO | RGD:736497 | 6480464 | perfluorooctanoic acid results in increased expression of MAPT protein | CTD | PMID:19211617 |
| phosgene | affects expression | ISO | RGD:736497 | 6480464 | Phosgene affects the expression of MAPT mRNA | CTD | PMID:16300373 |
| podophyllotoxin | decreases expression | EXP | | 6480464 | Podophyllotoxin results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| potassium chloride | multiple interactions | ISO | RGD:69329 | 6480464 | Okadaic Acid inhibits the reaction [Potassium Chloride results in decreased phosphorylation of MAPT protein] | CTD | PMID:9200503 |
| potassium chloride | decreases phosphorylation | ISO | RGD:69329 | 6480464 | Potassium Chloride results in decreased phosphorylation of MAPT protein | CTD | PMID:9200503 |
| pravastatin | affects expression | EXP | | 6480464 | Pravastatin affects the expression of MAPT | CTD | PMID:19461118 |
| progesterone | increases phosphorylation | ISO | RGD:69329 | 6480464 | Progesterone results in increased phosphorylation of MAPT protein | CTD | PMID:17443805 |
| progesterone | decreases expression | ISO | RGD:69329 | 6480464 | Progesterone results in decreased expression of MAPT protein | CTD | PMID:17443805 |
| pyrithione | multiple interactions | ISO | RGD:69329 | 6480464 | GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | CTD | PMID:17098228 |
| resveratrol | increases expression | ISO | RGD:736497 | 6480464 | resveratrol results in increased expression of MAPT mRNA | CTD | PMID:22610192 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MAPT mRNA | CTD | PMID:12569576 |
| Ro 31-8220 | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Arachidonic Acid results in increased phosphorylation of MAPT protein] | CTD | PMID:12605413 |
| rotenone | increases expression | ISO | RGD:69329 | 6480464 | Rotenone results in increased expression of MAPT protein | CTD | PMID:16219024 |
| rotenone | increases phosphorylation | ISO | RGD:69329 | 6480464 | Rotenone results in increased phosphorylation of MAPT protein | CTD | PMID:16219024 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of MAPT protein | CTD | PMID:16930453 |
| scopolamine | decreases expression | ISO | RGD:69329 | 6480464 | Scopolamine Hydrobromide results in decreased expression of MAPT mRNA | CTD | PMID:12818353 |
| simvastatin | affects expression | EXP | | 6480464 | Simvastatin affects the expression of MAPT | CTD | PMID:19461118 |
| staurosporine | multiple interactions | EXP | | 6480464 | Staurosporine inhibits the reaction [oxophenylarsine results in increased phosphorylation of MAPT protein] | CTD | PMID:10737602 |
| staurosporine | multiple interactions | ISO | RGD:69329 | 6480464 | Staurosporine inhibits the reaction [oxophenylarsine results in increased phosphorylation of MAPT protein] | CTD | PMID:10737602 |
| tamoxifen | multiple interactions | EXP | | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased expression of MAPT protein] | CTD | PMID:20579400 |
| tamoxifen | affects expression | ISO | RGD:736497 | 6480464 | Tamoxifen affects the expression of MAPT mRNA | CTD | PMID:17555576 |
| tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of MAPT protein | CTD | PMID:20579400 |
| testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of MAPT mRNA | CTD | PMID:17440010 |
| tetrachloromethane | affects expression | ISO | RGD:736497 | 6480464 | Carbon Tetrachloride affects the expression of MAPT mRNA | CTD | PMID:17484886 |
| tetrachloromethane | decreases expression | ISO | RGD:69329 | 6480464 | Carbon Tetrachloride results in decreased expression of MAPT mRNA | CTD | PMID:16644059 |
| trans-resveratrol | increases expression | ISO | RGD:736497 | 6480464 | resveratrol results in increased expression of MAPT mRNA | CTD | PMID:22610192 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of MAPT mRNA | CTD | PMID:12569576 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of MAPT mRNA | CTD | PMID:19101580 |
| vancomycin | increases expression | ISO | RGD:736497 | 6480464 | Vancomycin results in increased expression of MAPT mRNA | CTD | PMID:18930951 |
| wortmannin | increases phosphorylation | ISO | RGD:736497 | 6480464 | wortmannin results in increased phosphorylation of MAPT protein | CTD | PMID:15842767 |
| wortmannin | multiple interactions | ISO | RGD:736497 | 6480464 | Vitamin E inhibits the reaction [wortmannin results in increased phosphorylation of MAPT protein]; more ... | CTD | PMID:15842767 |
| zinc atom | multiple interactions | ISO | RGD:69329 | 6480464 | GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | CTD | PMID:17098228 |
| zinc(0) | multiple interactions | ISO | RGD:69329 | 6480464 | GSK3B protein promotes the reaction [[Zinc co-treated with pyrithione] results in increased phosphorylation of MAPT protein] | CTD | PMID:17098228 |